- Home
- BRLT vs ENLV Comparison
BRLT vs ENLV Comparison
Compare BRLT & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLT
- ENLV
- Stock Information
- Founded
- BRLT 2005
- ENLV 2005
- Country
- BRLT United States
- ENLV Israel
- Employees
- BRLT N/A
- ENLV N/A
- Industry
- BRLT Consumer Specialties
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- BRLT Consumer Discretionary
- ENLV Health Care
- Exchange
- BRLT Nasdaq
- ENLV Nasdaq
- Market Cap
- BRLT 21.8M
- ENLV 23.7M
- IPO Year
- BRLT 2021
- ENLV 1995
- Fundamental
- Price
- BRLT $1.38
- ENLV $1.18
- Analyst Decision
- BRLT Hold
- ENLV Strong Buy
- Analyst Count
- BRLT 3
- ENLV 2
- Target Price
- BRLT $1.80
- ENLV $10.00
- AVG Volume (30 Days)
- BRLT 54.4K
- ENLV 86.1K
- Earning Date
- BRLT 08-07-2025
- ENLV 05-30-2025
- Dividend Yield
- BRLT N/A
- ENLV N/A
- EPS Growth
- BRLT N/A
- ENLV N/A
- EPS
- BRLT N/A
- ENLV N/A
- Revenue
- BRLT $418,708,000.00
- ENLV N/A
- Revenue This Year
- BRLT $3.79
- ENLV N/A
- Revenue Next Year
- BRLT $3.85
- ENLV N/A
- P/E Ratio
- BRLT N/A
- ENLV N/A
- Revenue Growth
- BRLT N/A
- ENLV N/A
- 52 Week Low
- BRLT $1.25
- ENLV $0.81
- 52 Week High
- BRLT $2.68
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- BRLT 49.19
- ENLV 69.48
- Support Level
- BRLT $1.32
- ENLV $0.90
- Resistance Level
- BRLT $1.40
- ENLV $1.30
- Average True Range (ATR)
- BRLT 0.05
- ENLV 0.08
- MACD
- BRLT 0.00
- ENLV 0.03
- Stochastic Oscillator
- BRLT 50.00
- ENLV 77.50
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.